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Poliovirus-based vectors (replicons) have been shown to maintain the in vitro tropism of poliovirus for motor neurons of the CNS. To
determine if replicons could be effective for delivery of potentially beneficial proteins to the CNS, we have constructed and characterized a
replicon encoding IL-10. IL-10 was rapidly produced in tissue culture cells following in vitro infection with replicons encoding IL-10.
Intrathecal inoculation of replicons encoding IL-10 into the non-injured CNS of mice transgenic for the poliovirus receptor resulted in
expression of IL-10 within motor neurons at 24–48 h post-inoculation, which subsided by 72–96 h post-inoculation. Single intrathecal or
intramuscular injections of replicons were given following spinal cord trauma. Animals receiving replicons encoding IL-10 demonstrated a
greater functional recovery in the first 24 h after injury that was maintained throughout the testing period. Compared to animals given
replicons encoding gfp, CNS tissue from animals given replicons encoding IL-10 revealed extensive expression of IL-10 from astrocytes
around the CNS lesion during the first week following injury. The expression of IL-10 from astrocytes also correlated with more resting
microglia as opposed to the rounded activated microglia seen in animals given replicons encoding gfp. Results of these studies establish that
replicons can be used to express biologically active molecules in motor neurons of the CNS and these biologically active molecules can have
a direct effect on the CNS or induce a cascade of molecules that can influence the cellular composition and activation state of cells within the
CNS.
D 2005 Elsevier Inc. All rights reserved.Keywords: Poliovirus replicons; IL-10; Spinal cord injuryIntroduction
Poliovirus belongs to the family Picornaviridiae, a
family of small RNA viruses, and is the causative agent of
poliomyelitis. Poliovirus infection in primates and humans
results in destruction of motor neurons at all levels of the
spinal cord, brain stem, and motor cortex (Bodian, 1949;
Bodian and Howe, 1955). As a consequence of this
destruction, an acute paralytic disease of the central nervous0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.03.025
* Corresponding author. Fax: +1 205 934 5733.
E-mail address: caseym@uab.edu (C.D. Morrow).system occurs which is referred to as poliomyelitis (Bodian,
1949; Bodian and Howe, 1955). Studies on the pathogenesis
of poliovirus have been facilitated by the development of a
small animal model (transgenic mice) that expresses the
poliovirus receptor (PVR). Infection of these animals by a
variety of routes leads to the generation of symptoms
including paralysis, respiratory difficulties, and death
(Deatly et al., 1998, 1999; Ren and Racaniello, 1992a,
1992b).
The in vivo tropism of poliovirus for motor neurons has
been exploited by our laboratory in the development of
recombinant poliovirus genomes to deliver and express
foreign proteins in motor neurons (Bledsoe et al., 2000a,05) 173 – 183
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this laboratory have described the construction and charac-
terization of poliovirus genomes in which the capsid genes
in poliovirus have been substituted with a variety of foreign
genes (Ansardi et al., 2001; Novak et al., 2003; Porter et al.,
1995; Porter et al., 1996, 1998). These RNA genomes,
referred to as replicons, still retain the capacity to undergo
self-amplification and expression of foreign genes in the
cytoplasm of cells. Because the replicons are generated by
providing the capsid proteins in trans, they can undergo only
a single round of replication in the infected cell and do not
spread to infect other cells. Consequently, replicons encod-
ing reporter genes such as luciferase or green fluorescent
protein (gfp) are safe when given directly into the CNS of
transgenic mice or through peripheral routes (Bledsoe et al.,
2000a, 2000b; Jackson et al., 2001, 2003).
In previous studies, we have characterized the in vivo
expression of foreign proteins from poliovirus replicons
following infection of motor neurons in PVR transgenic
mice (Bledsoe et al., 2000a, 2000b; Jackson et al., 2001,
2003). Our results demonstrated that following infection,
motor neurons expressed the foreign proteins for up to 72
h post-inoculation; after that time, protein expression
within motor neurons dramatically decreased. Poliovirus
replicons maintained the tropism for motor neurons within
the CNS, and infection of other resident cell types was not
seen. The transient, high-level expression of foreign
proteins in the CNS using poliovirus replicon vectors
prompted us to assess the effects of replicons encoding
biologically active proteins within the CNS. Towards this
goal, in a previous study, we reported the effects of
administration of replicons encoding TNF-a into the CNS
(Bledsoe et al., 2000a, 2000b). The expression of TNF-a
within the CNS of these mice resulted in pleotropic effects,
including behavioral abnormalities and CNS tissue dam-
age. The results of this study established that replicons
could be used to express biologically active molecules
within the CNS.
In the current study, we have further exploited the
capacity of replicons to deliver biologically active mole-
cules to the CNS. For these studies, we have constructed
replicons which encode the gene for IL-10, since IL-10 is
a potent anti-inflammatory cytokine that reduces inflam-
mation and improves functional outcome in human and
animal models of inflammatory disease (Abraham et al.,
2004; Bethea et al., 1999; Pearse et al., 2004; Plunkett et
al., 2001; Takami et al., 2002). Within the CNS, IL-10
reduces TNF-a production by astrocytes and antigen
presentation by both astrocytes and microglial cells
(Balasingam and Yong, 1996). In vivo studies have
demonstrated that a single, systemic dose of IL-10 blocks
cytokine production and infiltration of inflammatory cells
in an experimental model of CNS inflammation (Crisi et
al., 1995; Fiorentino et al., 1991). Systemic administration
of IL-10 following spinal cord injury (SCI) has been
shown to result in enhanced sensorimotor recovery and adecrease in pain responses (Abraham et al., 2004; Bethea
et al., 1999; Pearse et al., 2004; Plunkett et al., 2001;
Takami et al., 2002). We have utilized a spinal cord injury
model in the PVR transgenic mice to determine whether
administration of replicons encoding IL-10 would provide
a similar therapeutic benefit following injury. We found
that animals given replicons encoding IL-10 following
injury exhibited a greater functional recovery than those
given control gfp replicons. The recovery correlated with
an increased expression of IL-10 and reduction in the
inflammatory response near the site of the CNS damage.
The results of our study demonstrate the capacity of
replicons to deliver biologically active molecules to the
CNS and support the concept that early intervention to
prevent inflammation can exert long-term benefits in
functional recovery from spinal cord injury.Results
Construction and characterization of a replicon encoding
IL-10
In previous studies, we have described the methods for
construction and characterization of replicons encoding
foreign genes (Jackson et al., 2001; Novak et al., 2003).
The gene encoding murine IL-10 was inserted into the
poliovirus genome between the VP2 and 2A genes (Fig.
1A). The IL-10 gene was inserted downstream from the
coding sequences for the FMDV self-cleaving peptide and
upstream of a series of amino acids encoding the 2A
protease cleavage site (Fig. 1B). The construct was designed
to maintain a translational reading frame between the VP4/
VP2 genes and the remaining non-structural poliovirus
genes. Replicon RNA genomes encoding the IL-10 gene
were generated using an in vitro transcription system. In
preliminary studies, we found that transfection of this RNA
into cells resulted in the expression of the appropriate virus
proteins (i.e., 3Dpol) as determined by immunoprecipitation
assays; IL-10 expression was confirmed using an antibody
specific for IL-10 (data not shown).
The replicon was encapsidated into poliovirions using a
complementation system, and encapsidated replicons were
purified by ultra-centrifugation followed by titer determi-
nation as previously described (Novak et al., 2003).
Expression of IL-10 was demonstrated following infection
of HeLa cells for 6 h with encapsidated replicons encoding
IL-10; encapsidated replicons encoding gfp served as a
control for these experiments. The IL-10 expression within
the cells was analyzed using an ELISA, which detects
biologically active IL-10 (Fig. 1C). Cells infected with the
replicon encoding IL-10 yielded an average of 200 pg/mL
of IL-10 over background activity (three independent
experiments).
To further analyze the expression of IL-10 in replicon-
infected HeLa cells, we analyzed expression using immuno-
Fig. 1. Construction and gene expression for replicons encoding IL-10. (Panel A) Schematic representation of the poliovirus genome. The complete cDNA of
poliovirus in the plasmid-designated pT7-IC is positioned downstream from a promoter for the bacteriophage T7 RNA polymerase. This promoter allows for in
vitro transcription of full-length RNA when templates are linearized at the SalI restriction site. (Panel B) Schematic representation of poliovirus replicon that
encodes murine IL-10 (IL-10). The gene encoding IL-10 was amplified by PCR and subcloned into the vector pGEM-T easy. The oligonucleotides were chosen
so that unique XhoI and SnaBI restriction endonuclease sites were added to the 5V and 3V end of the gene, respectively. The IL-10 gene was isolated by
restriction digestion with XhoI and SnaBI and subcloned into the poliovirus cDNA, resulting in the deletion of the coding region for VP3 and VP1 in the
poliovirus genome. In addition, the genome sequence encoding a 20 amino acid self-cleavage peptide of FMDV was cloned between the VP2 and IL-10 genes.
The resulting plasmid contains the IL-10 gene positioned between the genes encoding the VP2 self-cleavage site and 2A, thereby conserving the translational
reading frame. A replicon encoding green fluorescent protein (gfp) was constructed to serve as a control (Novak et al., 2003). (Panel C) In vitro analysis of IL-
10 production. HeLa cells were infected with the replicon encoding IL-10 or the replicon encoding gfp for 6 h. IL-10 expression in the cells using an ELISA.
The results shown are representative of the cell values for three separate experiments. (Panel D) Immunofluorescent analysis of replicon-infected HeLa cells.
HeLa cells were infected with the replicon encoding IL-10 or the replicon encoding gfp at a similar multiplicity of infection and incubated overnight. IL-10
expression in the cell cultures was examined using an IL-10 antibody and a secondary antibody conjugated to Alexa 594. Panel a, cells infected with the IL-10
replicon; and panel b, similarly treated cells processed without the primary anti-IL-10 antibody. Scale bar equals 40 Am.
C.A. Jackson et al. / Virology 336 (2005) 173–183 175fluorescence with antibodies specific for IL-10. At 24 h
post-infection, HeLa cells infected with the replicon
encoding IL-10 exhibited a strong immunofluorescence
using antibodies specific for IL-10 (Fig. 1D). At longer
times of infection (72–96 h), we observed extensive cell
death (Ansardi et al., 2001). As expected, the expressionwas contained mainly within the cytoplasm of the replicon-
infected cells, consistent with the exclusive cytoplasmic
location of poliovirus replication. Thus, the IL-10 expressed
from the replicons maintains the capacity to be recognized
by both an ELISA and by immunohistochemistry performed
on replicon-infected cells.
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administration of replicons
The distribution of IL-10 expression following replicon
infection was analyzed in mice transgenic for the poliovirus
receptor (PVR mice) that received a single intrathecal
injection of replicons encoding IL-10 or gfp. The replicons
were injected into the cerebrospinal fluid (csf) to access the
subarachnoid space at the level of the cauda equina. This
technique causes minimal damage to the spinal cord as
assessed by behavioral and histological analysis (Jackson et
al., 2001). A second series of PVR mice received
intramuscular injections of replicons encoding IL-10 or
gfp into the semitendinosus muscle of the right hindlimb,
which is innervated by the sciatic nerve. Transport of
replicons via the sciatic nerve results in infection of
motorneurons within the spinal cord (Jackson et al.,
2003). The spinal cords of two mice were analyzed at
each survival time for both replicons. Consistent with
previous studies, histological processing and routine
hematoxylin and eosin stains did not reveal any influx of
inflammatory cells due to the injection procedures or the
replicon infection (data not shown).Fig. 2. Distribution of IL-10 expression within the spinal cord following
administration of replicons encoding IL-10 or gfp. (Panel a) Low power
view of a longitudinal frozen section through the lumbar enlargement of the
spinal cord in a PVR transgenic mouse that had received a single injection
of replicons encoding IL-10 24 h earlier. Anti-IL-10 staining using a
biotinylated secondary and an Alexa 488 (green) reveals IL-10 expression
within the grey matter in the center of the spinal cord and intense IL-10
expression distributed across the surrounding white matter. The white arrow
marks the pial surface of the cord in this and the following panels. Scale bar
equals 80 Am. wm, white matter; gm, grey matter. (Panel b) Adjacent
section taken from the animal shown in panel a, processed without the
addition of primary antibody. (Panel c) Higher power view of a longitudinal
frozen section through the white matter in the lumbar spinal cord of a PVR
mouse that had received a single intrathecal injection of replicons encoding
IL-10 72 h earlier. Anti-IL-10 staining using a biotinylated secondary and
an Alexa 488 (green) revealed IL-10 expression within the subpial
astrocytes at the surface (arrow) and within the fibrous astrocytes of the
white matter. Scale bar equals 40 Am in this and the following panels.
(Panel d) Higher power view of a longitudinal frozen section through the
white matter in the lumbar spinal cord of a PVR mouse that had received a
single intramuscular injection of replicons encoding IL-10 into the
semitendinosus muscle 72 h earlier. Anti-IL-10 staining using a biotinylated
secondary and an Alexa 488 (green) fluorochrome revealed IL-10
expression following intramuscular administration within the subpial
astrocytes at the surface (arrow) and within the fibrous astrocytes of the
white matter is less widely distributed than that seen after intrathecal
injection in panel c. (Panel e) Higher power view of a longitudinal frozen
section through the white matter in the lumbar spinal cord of a PVR mouse
that had received a single intrathecal injection of replicons encoding gfp 72
h earlier. Anti-IL-10 staining using a biotinylated secondary and an Alexa
488 (green) fluorochrome revealed a limited amount of IL-10 expression
within the subpial astrocytes at the surface (arrow). (Panel f) Higher power
view of a longitudinal frozen section through the white matter in the lumbar
spinal cord of a PVR mouse that had received a single intrathecal injection
of artificial csf 72 h earlier. Anti-IL-10 staining using a biotinylated
secondary and an Alexa 488 (green) fluorochrome revealed a negligible
amount IL-10 expression within the white matter of the spinal cord.Previous studies utilizing a replicon encoding gfp have
shown that intrathecal administration results in foreign gene
expression localized to neurons throughout all levels of the
spinal cord and brainstem (Jackson et al., 2001). Intra-
muscular injection of replicons encoding gfp into the
hindlimb muscles resulted in expression within motor
neurons primarily in the lumbar cord (Jackson et al.,
2003). In the normal CNS, however, IL-10 and IL-10
receptor expression has been found mainly in astrocytes and
microglia and rarely in neurons (Hulfshof et al., 2002). To
determine whether IL-10 expressed by replicons was
localized in neurons, we analyzed IL-10 expression follow-
ing intrathecal or intramuscular inoculation of replicons
(Fig. 2). A low power view of a frozen section through the
lumbar enlargement of the spinal cord in a PVR transgenic
mouse that had received a single intrathecal injection of
replicons encoding IL-10 24 h earlier revealed abundant IL-
10 expression in both the white and grey matter (Fig. 2a); an
adjacent tissue section processed without primary antibody
revealed only diffuse autofluorescence (Fig. 2b). A higher
power view of sections from the same animal revealed
extensive IL-10 expression in the white matter in PVR mice
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(Fig. 2c); intramuscular injections produced a similar, but
less, pronounced result (Fig. 2d). Limited expression of IL-
10 in subpial astrocytes is seen in the spinal cords of PVR
mice that received injections of gfp replicons (Fig. 2e) or
artificial cerebrospinal fluid (csf) (Fig. 2f).
Cellular localization of IL-10 expression within the grey
matter revealed IL-10 expression within the cytoplasm of
large triangularly shaped cells characteristic of motorneur-
ons (Fig. 3a). The same cells were labeled using an antibody
specific for neurons (NeuN; Fig. 3b). IL-10 expression in
neurons from replicons was only found 24–48 h post-
infection, was entirely cytoplasmic, and does not co-localize
with the Hoechst nuclear counter stain (Figs. 3c and 3d). No
IL-10 expression was seen at this time in microglia or
oligodendrocytes (data not shown).Previous studies have shown that IL-10 can induce
expression of IL-10 within the CNS due to the autocrine
expression of IL-10 in astrocytes (Balasingam and Yong,
1996). A longitudinal frozen section through the lumbar
enlargement of the spinal cord in a PVR transgenic mouse
that had received a single intrathecal injection of replicons
encoding IL-10 24 h earlier revealed extensive IL-10
expression in the subpial and fibrous astrocytes of the
white matter and occasionally in the protoplasmic astrocytes
of the grey matter (Fig. 3e). Co-localization of the IL-10
expression with staining for GFAP, a marker for astrocytes
(Fig. 3f and nuclear counterstain, Fig. 3g), revealed IL-10
expression was evident throughout the entire process of
each astrocytic cell type, and not just the cell body (Fig. 3h).
Although the astrocytes of the spinal cord were not infected
by replicons, they demonstrated marked IL-10 expression
throughout the first week after injection of replicons
encoding IL-10; this was presumably due to an autocrine
effect following exposure to the IL-10 produced initially by
replicon-infected motorneurons. This conclusion is further
supported by analysis of the extent and distribution of the
patterns of IL-10 activity seen following injections of the
control gfp replicon or artificial csf, where little IL-10
expression was induced in astrocytes.Fig. 3. Cellular distribution of IL-10 expression within the grey matter of
the spinal cord. (Panel a) IL-10 expression within a longitudinal frozen
section through the white matter in the lumbar spinal cord of a PVR
mouse that had received a single intramuscular injection of replicons
encoding IL-10 24 h earlier. Anti-IL-10 staining using a biotinylated
secondary and an Alexa 488 (green) fluorochrome reveals IL-10
expression throughout from within the cytoplasm of large, triangularly
shaped cells characteristic of motorneurons (white arrow). Scale bar
equals 25 Am in this and all the following panels. wm, white matter; gm,
grey matter. (Panel b) The neuronal identity of these cells is confirmed by
the use of a NeuN antibody conjugated to an Alexa 594 (red)
fluorochrome (white arrow). (Panel c) The nuclei of cells within the
section, including the neurons (white arrow), were identified with a
Hoechst counterstain (blue). (Panel d) Merged view of panels a–c,
demonstrating the co-localization of IL-10 expression; NeuN is a marker
against neuronal nuclei that is also exhibited within the neuronal
cytoplasm, where it co-localizes with IL-10 (yellow). This co-localization
was most evident in tissue sacrificed 24–48 h after injection. IL-10
expression is entirely cytoplasmic and absent from the nucleus. gm, grey
matter; wm, white matter. (Panel e) Longitudinal frozen section through
the lumbar enlargement of the spinal cord in a PVR transgenic mouse that
had received a single injection of replicons encoding IL-10 24 h earlier.
Anti-IL-10 staining using a biotinylated secondary and an Alexa 488
(green) fluorochrome revealed that IL-10 expression was localized
primarily in the subpial and fibrous astrocytes of the white matter (open
arrow) and occasionally in the protoplasmic astrocytes of the grey matter
(open arrow). (Panel f) Same section as in panel e, processed with a
monoclonal antibody against GFAP, a marker for astrocytes, and a
secondary antibody conjugated to an Alexa 594 (red) fluorochrome.
Intense GFAP is evident in the subpial and fibrocytic astrocytes and
within protoplasmic astrocytes of the grey matter (open arrows). (Panel g)
Hoechst counterstain (blue) demonstrating nuclei of cells within the
section delineates the border between the white matter and grey matter of
the spinal cord (open arrows). (Panel h) Merged view of panels e–g,
demonstrating the co-localization of IL-10 activity and GFAP expression
in all astrocytic types (open arrows).
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Recombinant IL-10 protein has been analyzed previously
for its therapeutic effects following spinal cord injury and
has been shown to improve functional outcome (Abraham et
al., 2004; Bethea et al., 1999; Pearse et al., 2004; Plunkett et
al., 2001; Takami et al., 2002). To ascertain whether the IL-
10 produced by the replicons would exhibit a similar or
more marked effect on functional outcome after injury,
severe contusive spinal cord injuries were performed on
PVR transgenic mice using a weight drop method (Kuhn
and Wrathall, 1998). Immediately following injury, intra-
thecal injections of replicons encoding gfp (N = 10) or IL-10
(N = 10) were made using a 30-gauge needle inserted into
the csf in the subarachnoid space (Jackson et al., 2001).
Additional groups of PVR mice received replicons encoding
IL-10 (N = 10) or gfp (N = 10) via intramuscular injection.
All animals were tested before and after surgery with a
series of tests designed to assess a range of sensory and
locomotor skills. Testing was performed prior to surgery
(Day 0), the day following surgery (Day 1), and at weeklyFig. 4. Behavioral testing of mice following spinal cord injury and administration o
method adapted from Kuhn and Wrathall (1998). Immediately following injury, in
circles) or IL-10 (N = 10) (open diamonds) were made using a 30-gauge needle ins
al., 2001). A second group of animals received intramuscular injections of 108 repli
animals per each group. All animals were tested before and after surgery with a s
twelve tests were weighted to compose a 100-point scale, the Combined Mouse Be
weekly intervals up to 8 weeks. Values presented are the mean and standard error o
the test utilizing the BBB scale (bottom panels). IT, intrathecal; IM, intramusculaintervals for 8 weeks. The tests included a free field
observation scale modified from the Basso, Beattie, and
Bresnahan Score (BBB), a reflex test for toe spread, an
inclined plane test (Rivlin and Tator, 1977), a rope hang,
platform hang, and wire mesh test, a reversal test, a timed
distance test, a free field swimming test, and an evaluation
of overall health. The twelve tests are weighted to compose
a 100-point scale, the Combined Mouse Behavioral Score
(CMBS) (Fig. 4). The differences in behavior in mice
receiving IL-10 replicons were evident as early as 24 h after
injury in the first testing session and were maintained
throughout the 8 weeks of testing. Statistical analyses
utilizing the Kruskal–Wallis nonparametric analysis of
variance test and an ANOVA with the Bonferroni post hoc
correction revealed that the difference between the IL-10
group and the gfp group was statistically significant at the
P < 0.05 level at all time points tested. The increase in
functional recovery with the IL-10 replicons was evident
when the replicons were given by either intrathecal or
intramuscular routes and was significant using BBB sub-
score or CMBS.f replicons. Severe spinal cord injuries were performed using a weight drop
trathecal injections of 10 Al of 108 replicons encoding gfp (N = 10) (closed
erted into the cerebrospinal fluid (csf) in the subarachnoid space (Jackson et
cons encoding gfp (closed circles) or IL-10 (open diamonds). There were 10
eries of tests designed to test a range of sensory and locomotor skills. The
havioral Score (CMBS). Testing was performed the day after surgery and at
f the mean for the CMBS scores (top panels) and the sensorimotor portion of
r.
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taken from injured mice treated with IL-10 or gfp replicons
was performed to determine the cell types involved in
mediating the functional improvement seen with the IL-10
replicons in the chronic injury groups described above. Two
groups of PVR mice were given spinal cord contusions and
intrathecal injection of replicons and were allowed to
survive for 24, 72, and 96 h. Two animals were examined
at each time interval for each group. All animals were tested
the day after surgery to confirm the severity of the injury,
and scores ranged from 29 to 35 on the CMBS scale. Within
the primary site of injury (i.e., injury center), IL-10
expression was found within astrocytic processes extending
throughout the entire extent of the white matter. Co-
localization of IL-10 expression and markers for micro-
glia/macrophages revealed CD11b expression in small
rounded cells, whose size and shape were characteristic of
activated microglia or infiltrating blood-borne macrophages;
additional experiments will be needed to ascertain the origin
of these cells. Differences in the pattern of IL-10 expression
and the morphology of cell types within the spinal cord were
more remarkable in tissue located approximately 1 mm or
more away from the injury center. This tissue is less affected
by the necrotic changes, but is susceptible to damage by
secondary processes such as inflammation, reactive oxygen
species, and nitric oxide production. IL-10 expression in this
area of the injured spinal cord was more pronounced in PVR
mice that received replicons encoding IL-10. Visualization
of CD11b from animals given IL-10 replicons revealed
highly ramified (resting) microglial profiles (Fig. 5a). In
contrast, tissue taken from a similar location in the spinal
cord of a PVR mouse that had received an injection of gfp
replicons 72 h earlier contained rounded cell profilesFig. 5. Distribution of IL-10 expression within the spinal cord following
spinal cord injury and administration of replicons encoding IL-10 or gfp.
(Panel a) Longitudinal frozen section through the white matter approx-
imately 1 mm away from the injury site in the spinal cord in a PVR mouse
that had received an injury and an injection of IL-10 replicons 72 h earlier.
Visualization of CD11b with an Alexa 594 fluorochrome (red) reveals
highly ramified microglial profiles (open white arrow). The scale bar in this
and the following image is 40 Am; wm, white matter; gm, grey matter.
(Panel b) Longitudinal frozen section through the white matter approx-
imately 1 mm away from the injury site in the spinal cord in a PVR mouse
that had received injury and injection of gfp replicons 72 h earlier. Cd11b is
visualized with an Alexa 594 (red) fluorochrome and extends throughout
the white matter. Rounded profiles characteristic of activated microglia
(white arrows) are present.characteristic of activated microglia which are associated
with deleterious inflammatory responses (Fig. 5b). The
CD11b-positive cells were distributed throughout the white
matter and the grey matter and were particularly numerous
surrounding blood vessels. Thus, the primary morphological
difference between the injured spinal cords of animals
receiving IL-10 or gfp replicons was the appearance of
ramified (normal, resting) microglia surrounding the injury
site for a period of 1–3 days after injury in those animals
receiving IL-10 replicons.Discussion
In this study, we have further investigated the potential of
poliovirus replicons encoding foreign proteins for gene
delivery to the CNS. Poliovirus replicons encoding IL-10
were constructed and shown to express this protein
following infection of tissue culture cells in vitro. The
cellular specificity of the replicons within the spinal cord
was analyzed following single intrathecal or intramuscular
injections of poliovirus transgenic mice. Within 24 h after
inoculation, the IL-10 co-localized with motor neurons of
the spinal cord. At later intervals, enhanced IL-10 expres-
sion was evident in astrocytes, presumably due to an
autocrine effect of neuronally produced IL-10 on surround-
ing astrocytes. The biological function of IL-10 expressed
within the CNS from poliovirus replicons was evaluated
using a spinal cord injury model. In this case, expression of
IL-10 in the CNS from replicons inoculated via the
intrathecal or intramuscular routes resulted in enhancement
of functional recovery from spinal cord injury. The recovery
correlated with a reduction in the inflammatory response in
the spinal cord surrounding the injury site that occurs in the
first week following injury.
The results of our former and current studies support the
concept that poliovirus replicons have the capacity to safely
deliver biologically active molecules to the CNS. Previ-
ously, we have analyzed poliovirus replicons encoding gfp
or luciferase for the capacity to express these proteins within
the CNS (Bledsoe et al., 2000a, 2000b; Jackson et al.,
2001). The results of those studies, as well as our current
study, establish that poliovirus replicons maintain their
tropism for motor neurons of the CNS. Expression of IL-10
within motor neurons of the CNS following inoculation with
replicons did not appear to have any deleterious effect as
measured from behavioral testing or histological analysis.
Our study is the first demonstration of the use of
poliovirus replicons to express a biologically active mole-
cule that exerts a therapeutic effect. We chose IL-10 for
expression within the CNS because previous studies have
demonstrated that exogenous IL-10 has therapeutic potential
to improve functional recovery following spinal cord injury
(Abraham et al., 2004; Bethea et al., 1999; Pearse et al.,
2004; Plunkett et al., 2001; Takami et al., 2002). IL-10
suppresses the production of inflammatory cytokines such
C.A. Jackson et al. / Virology 336 (2005) 173–183180as TNF-a, matrix metalloproteinases, and other chemokines
(Balasingam and Yong, 1996; Fiorentino et al., 1991). IL-10
also prevents glutamate-induced neurotoxicity (Bachis et al.,
2001; Brodie, 1996; Grilli et al., 2000) and promotes NGF
production by astrocytes (Brodie, 1996). Reduction in pain
behavior was noted in rats following spinal cord injury and a
single systemic application of IL-10 (Plunkett et al., 2001).
Other studies, though, have shown that IL-10 treatments
following spinal cord injury decreased the amount of
damaged tissue and reduced macrophage infiltration but
did not result in functional recovery. These discrepancies
regarding the effectiveness of IL-10 are not only due to the
timing of the treatments during the disease injury process
but also to the route of administration of this potent
cytokine. Since IL-10 does not normally cross the blood–
brain barrier, it can only reach the CNS once the blood–
brain barrier has been disrupted (Kastin et al., 2003). Due to
the short half-life of cytokines in the body, supraphysiologic
amounts of IL-10 must be given to achieve a therapeutic
effect in the CNS. In addition, the pleotropic nature of IL-10
may cause additional effects on other organs and the
immune system. The use of replicons for the delivery of
IL-10 to the CNS could circumvent the problems associated
with the systemic administration of IL-10. Indeed, our
studies provide two routes in which IL-10 could potentially
be safely administered to the CNS (Jackson et al., 2003).
Direct intrathecal inoculation following damage would
ensure the access of IL-10 to the CNS. It is also possible
to deliver IL-10 via intramuscular inoculation following
CNS damage. With respect to this issue, it is important to
note that while most of the human population has been
immunized against poliovirus to protect against polio-
myelitis, a previous study from this laboratory has shown
that animals previously immuned to poliovirus are suscep-
tible to infection with replicons (Porter et al., 1997). Thus,
intramuscular inoculation of replicons even into poliovirus-
immune individuals should be feasible.
An additional, important point of using replicons for
delivery of biologically active molecules is the rapid and
short time frame for foreign gene expression within
neurons following inoculation. The kinetics of IL-10
expression within the CNS from the IL-10 replicon was
also similar to that seen for other proteins expressed from
replicons (Bledsoe et al., 2000a, 2000b; Jackson et al.,
2001). Peak expression occurred at 24 h post-inoculation
of the replicons and was confined exclusively to motor
neurons; expression of IL-10 within motorneurons was
absent at approximately 96 h post-inoculation. Indeed,
previous studies have shown that the effects of IL-10 are
manifested only when given early following CNS injury
(Bethea et al., 1999). At later times, IL-10 may have no
effect, or possibly be detrimental (Bethea et al., 1999;
Pearse et al., 2004). In contrast to expression of IL-10
from DNA-mediated gene delivery vectors, the rapid and
short-term expression of IL-10 from poliovirus replicons
probably facilitates the beneficial outcome of this treat-ment. In support of this conclusion, we have found that
additional administration of replicons encoding IL-10 to
injured animals during the first week after injury did not
significantly improve the functional recovery of these
animals. Clearly, additional experiments will be required to
establish the conditions to further improve the functional
recovery of animals following spinal cord injury. The
transient expression from replicons could permit the
sequential use of replicons encoding different molecules,
resulting in a cascade of potentially beneficial cytokines/
biologically active molecules in the CNS. One possibility
would be to give replicons encoding IL-10 early after
injury to prevent inflammation, followed later by replicons
encoding growth factors such as NT3 or NGF to
encourage axonal outgrowth and neuronal recovery. Since
replicons do have the potential to affect non-neuronal cells
within the CNS, as shown in this study where a cytokine
cascade occurred in astrocytes as a result of IL-10
expression in motor neurons, a therapeutic strategy could
be formulated to affect different CNS cell populations at
critical points in the recovery process to further enhance
functional recovery from spinal cord injury.Materials and methods
Replicon encoding IL-10
The complete cDNA of poliovirus in the plasmid
designated pT7-IC is positioned downstream from a
promoter for the bacteriophage T7 RNA polymerase, which
allows for in vitro transcription of full-length RNA when
templates are linearized at the Sal restriction site (Fig. 1A).
Taq polymerase was used to amplify the mouse IL-10
cDNA from PcD (SR alpha)-F115 (ATCC, #68027) using
primers: 5V -CCTCGAGCCTGGCTCAGCACTGCTATG-3V
and 5V -ACGTAGCTTTTCATTTTGAT GATCATGTATG-
3V. The PCR product was subcloned into the vector pGEM-T
Easy (Promega) and sequenced. The oligonucleotides were
chosen so that unique XhoI and SnaBI restriction endonu-
clease sites were added to the 5V and 3V end of the gene,
respectively. The IL-10 gene was isolated by restriction
digestion with XhoI and SnaBI and subcloned into the
poliovirus cDNA, resulting in the deletion of the coding
region for VP3 and VP1 in the poliovirus genome. In
addition, a sequence encoding the 20 amino acid self-
cleavage peptide of FMDV was cloned between the VP2 and
IL-10 genes. The resulting plasmid contained the IL-10 gene
positioned between the genes encoding VP2 self-cleavage
and 2A, thereby conserving the translational reading frame
(Fig. 1B). A replicon encoding green fluorescent protein
(gfp) was constructed to serve as control (Novak et al.,
2003). The replicons were serially passaged to high titer as
previously described. Assays for the presence of recombi-
nant (wild type) poliovirus, conducted by passaging repli-
cons in HeLa cells, were negative.
C.A. Jackson et al. / Virology 336 (2005) 173–183 181In vitro assay for IL-10
Replicons encoding IL-10 and gfp were used at a similar
multiplicity of infection to infect HeLa cells in 6-well plates.
After 6 h, supernatants and cells were collected; cells were
lysed by three consecutive freeze–thaw cycles. The IL-10
expression was analyzed using an ELISA assay (RD
Systems). The results shown are representative of the cell
values for three independent experiments.
Immunofluorescent analyses of replicon-infected HeLa cells
HeLa cells were infected with the replicon encoding IL-
10 and incubated overnight at 37 -C overnight. The cells
were fixed with 2% paraformaldehyde for 2 h at 4 -C and
rinsed with phosphate-buffered saline (PBS). IL-10 expres-
sion in cells was examined using a monoclonal antibody
against murine IL-10 (Chemicon, Inc) at a concentration of
1:500 at 4 -C overnight followed by a secondary antibody
conjugated to Alexa 594 (Molecular Probes, Inc) at a
concentration of 1:400 for 1 h at room temperature. After
rinsing with PBS, the cells were examined using a DMIRBE
Leica confocal microscope and a Krypton laser. Control
slides were imaged at the same laser intensity levels to
assess the level of background fluorescence due to fixation
and tissue processing.
Surgical procedures
PVR transgenic mice were anaesthetized with a mixture
of 3% Halothane with oxygen at a rate of 1 L/min, followed
by a maintenance dose of 1.5% Halothane. Corneal reflex
and breathing rates were continuously monitored throughout
the surgery. Following exposure of the spinal column, a
laminectomy was performed at the level of the dural sac
near the cauda equina. In this region, the spinal cord has
narrowed, and the cerebrospinal fluid bathing the cord is
readily accessible. A 30-gauge needle attached to a micro-
pipette was used for intrathecal injections of 10 Al of 108
replicons encoding IL-10 (N = 8), gfp (N = 8), or artificial
csf (N = 4), and the animals were sacrificed at 24, 48, 72, or
96 h after injection. Two animals were analyzed at each
survival time. Replicons have also been shown to infect
motor neurons via the intramuscular route (Jackson et al.,
2003). A second group of PVR mice received single
intramuscular injections of 20 Al of 108 replicons encoding
IL-10 (N = 8) or gfp (N = 8) into the right semitendinosus
muscle, thereby accessing the sciatic nerve and motor
neurons in the spinal cord. Two animals in each group were
sacrificed at 24, 72, and 96 h after injection.
For contusion injury, the spinal column was exposed in
the lower thoracic region, and a laminectomy was
performed at the T11 level. Care was taken to keep the
dura intact. A 3-g weight was applied to an impounder
carefully positioned at the surface of the spinal cord to
produce a contusion injury. After suturing overlyingmuscles, the skin was closed with surgical adhesive.
Postoperatively, the mice received lactated Ringer’s solution
subcutaneously and intramuscular injections of Baytril
antibiotic for 5 days. Bladder expression was performed
twice daily and the animals monitored for signs of infection
or discomfort. The Institutional Animal Care and Use
Committee of the University of Alabama at Birmingham
approved all procedures.
Following a severe contusion injury to the spinal cord,
single intrathecal injections of 10 Al of 108 replicons
encoding IL-10 (N = 10) or gfp (N = 10) were made using
a 30-gauge needle inserted into the subarachnoid space at
the level of the cauda equina. In the intramuscular groups,
single injections of 20 Al of 108 replicons encoding gfp (N =
10) or IL-10 (N = 10) were made into the right semite-
ndinosus muscle using a micropipette attached to a 30-
gauge needle (Jackson et al., 2003).
Behavioral assessment
Sensorimotor function of the spinal cord in all animals
was assessed using a series of behavioral tests that evaluate
a range of functional activities from reflex behavior to
coordinated locomotion. The 12 tests included a free field
observation scale modified from the Basso, Beattie, and
Breshnahan (BBB) scale used in rats, wire mesh, rope hang,
and platform hang (Kuhn and Wrathall, 1998), a reflex test
for toe spread, a timed distance walk, a reversal test, a free-
field swimming test, and an evaluation of overall health.
The tests are weighted on 100-point scale, the Combined
Mouse Behavioral Score (CMBS). The tests were performed
the day after surgery in all animals and for the following 8
weeks in the long-term survival groups. In animals receiving
intrathecal injections only, the tests served to ensure that the
injection was performed in a non-invasive manner, while in
the injured mice, the tests served to chart the time course of
recovery and the differences between treatment groups.
Comparisons between weekly scores for animals receiving
IL-10 replicons and those with control gfp replicons were
analyzed using the Kruskal–Wallis nonparametric analysis
of variance. ANOVA tests followed by a Bonferroni post
hoc test were also made at each interval after injury.
Differences were significant at the P < 0.05 level for both
CMBS and the BBB subscore.
Histological and immunofluorescent analyses
The mice were sacrificed using an overdose of ketamine
and xylazine followed by cardiac perfusion with saline and
4% paraformaldehyde. After 1–4 h of post-fixation at 4 oC,
the spinal cords were removed from the spinal column and
transferred to PBS with 0.1% paraformaldehyde or to 30%
sucrose for cryoprotection. The tissue was embedded in
OCT compound and sectioned at 16 Am on a cryostat in the
longitudinal plane. All sections were mounted on gelatin-
coated slides, air dried, and stored at 20 -C. Representative
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hematoxylin and eosin to compare the inflammatory cell
response and the extent of damaged tissue following
replicon injection and/or spinal cord injury.
Sections throughout the spinal cord were rinsed three
times in 0.1 M phosphate-buffered saline (PBS) and placed
in 10% normal donkey serum (NDS) diluted in a 0.3%
Triton X-100/PBS mixture for 1 h at room temperature to
prevent non-specific binding. Experimental slides were
incubated at 4 -C overnight in a 1:500 concentration of a
polyclonal murine IL-10 antibody (RD) in 0.3% Triton X-
100/PBS. Control slides were processed without the
addition of the primary antibody. Sections were rinsed three
times in PBS followed by a 1-h incubation at room
temperature with a biotinylated donkey anti-rabbit secon-
dary (Jackson Immunoresearch) diluted 1:400 with 0.3%
Triton-X100/PBS. After rinsing with PBS three times,
sections were incubated for 1 h at room temperature in
Alexa 488 streptavidin (Molecular Probes, Inc.) diluted
1:200 in 0.1 M PBS. Following two rinses in PBS, the slides
were placed in distilled water and coverslipped in Perma-
fluor or processed for co-localization.
Co-localization of neuronal and glial antigens was
performed using monoclonal antibodies and a 1:400
concentration of donkey anti-mouse or donkey anti-rat
secondaries conjugated with Alexa 594 (Molecular Probes,
Inc.). Neurons were identified using a 1:500 concentration
of NeuN (Chemicon, Inc.), a primary antibody directed
against neuronal nuclei. A 1:500 concentration of an
antibody against glial fibrillary acidic protein (GFAP)
(Sigma) was used to localize astrocytes: while anti-
MAB328 (Chemicon, Inc.) and anti-CNPase (Sigma) were
used to identify oligodendrocytes (1:500). Microglia were
characterized using an antibody against CD11b at 1:300
dilution (Serotec) or anti-F4/80 at a 1:50 dilution (RD).
Similar patterns of co-localization were obtained with both
microglial antibodies. Slides were counterstained for visual-
ization of the nucleus with a 1:2000 dilution of Hoechst
33258 (Sigma).
All slides were examined for IL-10 expression using a
Leitz Aristoplan light microscope. Fluorescent images were
recorded using a Leica DMIRBE confocal microscope
equipped with an ultraviolet laser for short wavelength
images, an argon laser for intermediate wavelengths, and a
krypton laser for long wavelength fluorochromes. Control
slides for each animal were shot at the same laser settings to
determine the level of background fluorescence resulting
from fixation and tissue processing. The images were
processed using Adobe Photoshop 6.0.Acknowledgments
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